Suzhou Rainmed Medical Technology Co., Ltd.

Founded in 2014, RainMed Medical is committed to becoming the world's leading vascular interventional robotics company. Currently, it is focusing on the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems. With independent innovation and great efforts, RainMed Medical has gradually built up a global R&D, production, sales and service network.

RainMed Medical has actively cooperated with top medical centers and experts at home and abroad to build a perfect patent system. Many research results are continuously published in authoritative journals such as “Cardiovascular Research” and “JACC: Cardiovascular Interventions”. In addition, the company has signed strategic cooperation agreements with many top medical device distribution service platforms in China, developed a strict quality inspection system and perfect supply process, and successfully passed the medical device quality management system certification.

In the future, RainMed Medical will uphold the purpose of " Targeted medical services for the people's health", rely on the experience in control algorithm, Image navigation, Image intelligence, evidence-based medicine, etc. to launch "Interventional Surgical Robot" and gradually build "Unmanned Operating Room". It aims to enhance the clinical value of products and create a new situation for the development of precision medicine in the interventional field. 


Has a perfect patent system


Published many papers in global authoritative journals such as "Cardiovascular Research", "JACC:Cardiovascular Interventions"



Address: Building 31, Northeast District, Nano City, No. 99 Jinji Lake Avenue, Suzhou industrial park


WeChat public account


Recruitment QR Code

Page Copyright© 2021- Suzhou Rainmed Medical Technology Co., Ltd.  苏公网安备32059002003601号  (苏)-非经营性-2021-0149